Tag Archives: treatment
Unfortunately infectious causes of chronic disease have been ignored and dismissed. Treatment may be denied in the acute phase of immortal infections in the name of protecting against antibiotic resistance, and by the time a chronic disease occurs the acute disease has long been forgotten. To prevent antibiotic resistance the best way is to reduce antibiotics in animals (80% of usage). It is not too many antibiotics, it is too many of the wrong antibiotics, and lack of adequate diagnosis…..
We have previously written about the benefits of Azithromax (Z-pack) in a variety of chronic diseases—and about early treatment of intracellular infections to limit the risk of developing a chronic infection. Azithromax is safe and available, and has been shown to be effective at stopping inflammation and blood clots, after influenza and other viral illnesses. Azithromax has been shown to reduce the risk of future cardiovascular events in patients with cardiac disease. Azithromax and is now being considered as a…..
This October 23, 2020 article was published in The American Medical Journal, and then republished on the same day at the NIH link. The article again supports our many previous posts suggesting the potential for an MMR vaccination to provide some protection against covid-19, and mitigate the severity of the disease. The article further supports the MMR vaccination is a potential explanation for mild and asymptomatic cases in children. Lax rates of MMR vaccination worldwide are correlated with worse rates…..
We suggested several times (3/21/20, 6/23/20, 8/6/20, 10/18/20) that childhood vaccines may provide cross reactivity, and protection or partial protection against covid19, particularly the MMR and polio vaccine. Childhood vaccinations provide one explanation for why children do not get covid19, are asymptomatic, or are less severely affected. Vaccinations also explain why some countries have had a lower rate of covid19 and covid19 death—the countries that had mass vaccination programs for the MMR. Other scientists are now also reporting childhood vaccinations,…..
We suggested in March and June of 2020 that studies and surveys be done to determine why children seem to be less effected by covid19, and that existing vaccines and other recent viral infections may provide partial protection against covid19. The Mayo Clinic has now reported one or more non-COVID, FDA-approved, readily available vaccines, may have some protective effect in covid19. Vaccines reported to have some protective effect included the MMR, the polio vaccine, the influenza vaccine, and the pneumonia…..
Research suggests childhood vaccines (MMR, BCG, and polio) may provide cross-reactivity and some protection against covid-19. Most people under 50 have received the MMR and polio vaccines. Starting in the 1990’s, children received two MMR vaccinations rather than one, when two was reported to give greater protection. Cross-reactivity with childhood vaccines could explain lesser symptoms or the absence of symptoms in children and younger adults; could provide an opportunity for stop-gap measures to control covid-19; and could provide new opportunities…..
Daraprim (pyrimethamine) was developed by a Nobel Prize winning American scientist, Gertrude Elion (1918-1999); and treats blood borne parasitic infections, such as malaria and toxoplasmosis. WHO reports Daraprim is one of the safest and most effective medicines that is needed in any health system. In clinical trials, Daraprim has been shown effective in treating HIV (HIV patients susceptible to toxoplasmosis), retinochoroiditis (retinal inflammation), and ALS (Lou Gehrig’s disease); and may slow the progression of Tay-Sachs disease, a “syndrome” in which…..
In 1988, Gertrude Elion (1918-1999), George Hitchings, and Sir James W. Black shared the Nobel Prize for physiology/medicine. They are credited with developing Daraprim, to treat blood borne parasitic infections (including malaria and toxoplasmosis). WHO reported Daraprim is one of the safest and most effective medicines needed in a health system. In clinical trials, Daraprim was shown to be effective in HIV, retinochoroiditis, ALS, and variety of other chronic diseases; and may slow the progression of Tay-Sachs disease, a syndrome…..
Cancer can occur in clusters, and is more common in caretakers of cancer patients, suggesting infectious causes. It has been proposed treatment of chlamydia pneumonia, in smokers, could reduce the risk of lung cancer. H-pylori can cause stomach cancer, and treatment of H-pylori was shown to reduce the incidence of stomach cancer. Heart attack and stroke occur more frequently after an outbreak of respiratory infections; and patients who took tetracycline, azithromycin, or clarithromycin, for any reason, during the prior three…..
Anti-vessel growth drugs (anti-VEGF) were first approved to treat gastrointestinal cancers, and the indications were subsequently expanded to other types of cancer. Doctors use anti-VEGF drugs in an effort to cut-off the blood supply to cancer, and thereby stop or slow the growth of cancer. Anti-VEGF drugs are expensive, at $30,000 per dose; and can cause unintended damage to adjacent tissue. Intracellular chlamydia pathogens damage oxygen transport, across the cell wall; and generate angiogenesis (formation of new blood vessels). Dr……
Recent Posts
- Antibiotic use in animals leads to antibiotic resistance
- New book supports chronic infections cause chronic diseases
- Diagnosing chronic intracellular pathogens may aid in understanding viral variants
- Chronic intracellular infection impacts acute viral infection
- Intracellular co-infections can create new viral variants
Recent Comments
Archives
- February 2021
- January 2021
- December 2020
- November 2020
- October 2020
- September 2020
- August 2020
- July 2020
- June 2020
- May 2020
- April 2020
- March 2020
- February 2020
- January 2020
- December 2019
- November 2019
- October 2019
- September 2019
- August 2019
- July 2019
- June 2019
- May 2019
- April 2019
- March 2019
- February 2019
- January 2019
- December 2018
- November 2018
- October 2018